Literature DB >> 16132579

Identification of molecular markers for metastasis-related genes in primary breast cancer cells.

Koshi Mimori1, Akemi Kataoka, Keiji Yoshinaga, Mitsuhiko Ohta, Yasuaki Sagara, Yasuji Yoshikawa, Shinji Ohno, Graham F Barnard, Masaki Mori.   

Abstract

Comparing differential gene expression profiles established by cDNA microarray between normal cells (N), primary carcinoma cells (T), and metastatic carcinoma cells (M) may determine those critical genes directly associated with progression and metastasis of breast cancer. Total RNA was extracted by laser microdissection (LMD) from 20 slices of T, N and M from 6 cases. After amplification by a T7-based system, differentially expressed genes between T, N and M were identified by cDNA microarray. In addition, to clarify the mechanism for altered gene expression, we determined the methylation status by sequencing after bisulfite treatment for intriguing genes. As a result, the expression of motility related protein-1 (MRP-1/CD9), peripheral myelin protein-22 (PMP-22), and caspase 3 (CASP-3) were down-regulated in M compared to T. We focused especially on MRP-1 and found that the expression status of MRP-1 was significantly inversely associated with stage of disease in 56 cases of breast cancer (P<0.05), and the relapse free survival in 5 years was significantly higher in MRP-1 positive cases than those negative cases (P<0.05). Conversely, overexpression, by 11-fold, of signal transduction and translation factors were observed in T compared to N. The cancer specific methylation was observed only in CASP-3 in a case. In conclusion, the establishment of the present assay allows us to detect genes directly associated with each cell population within tumor tissue and gives us clues to identify metastasis-related genes comprehensively in clinical breast cancer cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132579     DOI: 10.1007/s10585-005-4417-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  34 in total

Review 1.  Modulation of STAT signaling by STAT-interacting proteins.

Authors:  K Shuai
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

2.  Analysis of gene expression in ductal carcinoma in situ of the breast.

Authors:  Adewale Adeyinka; Ethan Emberley; Yulian Niu; Linda Snell; Leigh C Murphy; Heidi Sowter; Charles C Wykoff; Adrian L Harris; Peter H Watson
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

3.  Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics.

Authors:  T Megha; S Lazzi; F Ferrari; R Vatti; C M Howard; G Cevenini; L Leoncini; P Luzi; A Giordano; P Tosi
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

4.  A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells.

Authors:  Kazuhiko Aoyagi; Takeshi Tatsuta; Michiko Nishigaki; Shingo Akimoto; Chikako Tanabe; Yoko Omoto; Shin ichi Hayashi; Hiromi Sakamoto; Michiie Sakamoto; Teruhiko Yoshida; Masaaki Terada; Hiroki Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

5.  Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.

Authors:  K Yamashita; M Mori; T Shiraishi; K Shibuta; K Sugimachi
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

6.  p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.

Authors:  R Silvestrini; E Benini; S Veneroni; M G Daidone; G Tomasic; P Squicciarini; B Salvadori
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

7.  Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

Authors:  Andreas Widschwendter; Sibylle Tonko-Geymayer; Thomas Welte; Günter Daxenbichler; Christian Marth; Wolfgang Doppler
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

8.  Motility related protein 1 (MRP1/CD9) expression in colon cancer.

Authors:  M Mori; K Mimori; T Shiraishi; M Haraguchi; H Ueo; G F Barnard; T Akiyoshi
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

9.  Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.

Authors:  A Sierra; X Castellsagué; S Tórtola; A Escobedo; B Lloveras; M A Peinado; A Moreno; A Fabra
Journal:  Clin Cancer Res       Date:  1996-11       Impact factor: 12.531

10.  Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.

Authors:  Carmen Pingoud-Meier; Doris Lang; Anna J Janss; Lucy B Rorke; Peter C Phillips; Tarek Shalaby; Michael A Grotzer
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

View more
  21 in total

Review 1.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

2.  Heterogeneity of Bcl-2 expression in metastatic breast carcinoma.

Authors:  Andrea Proctor Subhawong; Hind Nassar; Marc K Halushka; Peter B Illei; Russell Vang; Pedram Argani
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

3.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

Review 4.  CD9, a tetraspanin target for cancer therapy?

Authors:  Aurelio Lorico; Marco Lorico-Rappa; Jana Karbanová; Denis Corbeil; Giuseppe Pizzorno
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-18

Review 5.  High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.

Authors:  Karin Rennstam; Ingrid Hedenfalk
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

6.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

7.  The palmitoylation state of PMP22 modulates epithelial cell morphology and migration.

Authors:  Susie J Zoltewicz; Sooyeon Lee; Vinita G Chittoor; Steven M Freeland; Sunitha Rangaraju; David A Zacharias; Lucia Notterpek
Journal:  ASN Neuro       Date:  2012-12-03       Impact factor: 4.146

Review 8.  Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.

Authors:  Vigdis Nygaard; Eivind Hovig
Journal:  Nucleic Acids Res       Date:  2006-02-09       Impact factor: 16.971

9.  Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

Authors:  David I Rodenhiser; Joseph Andrews; Wendy Kennette; Bekim Sadikovic; Ariel Mendlowitz; Alan B Tuck; Ann F Chambers
Journal:  Breast Cancer Res       Date:  2008-07-18       Impact factor: 6.466

10.  TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.

Authors:  Sandra V Fernandez; Catherine Bingham; Patricia Fittipaldi; Laura Austin; Juan Palazzo; Gary Palmer; Katherine Alpaugh; Massimo Cristofanilli
Journal:  Breast Cancer Res       Date:  2014-10-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.